Prospective Validation of DL Model for Postoperative MACCE Prediction
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Major Adverse Cardiovascular and Cerebrovascular Events (MACCE). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Prospective Validation of Deep Learning Model to Predict Postoperative Major Adverse Cardiac and Cerebrovascular Event
Overview
This study aims to prospectively validate a deep learning model developed using retrospective data to predict major adverse cardiac and cerebrovascular events (MACCE) occurring within 30 days after non-cardiac surgery. The validation will be performed using prospectively collected data from patients undergoing non-cardiac surgery under general or regional anesthesia.
Primary outcome measures
- Major adverse cardiovascular and cerebrovascular events (MACCE) [Time frame: within 30 days after surgery]
Eligibility criteria
Inclusion criteria
- Adults aged 18 or older undergoing non-cardiac surgery under general or regional anesthesia at Seoul National University Hospital
Exclusion criteria
- Reoperation within 30 days after initial surgery
- Organ procurement or pregnancy-related procedures
- Ambulatory-based surgery
- Preoperative tracheal intubation before entering the operating room
- Surgeries performed outside the operating room
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
South Korea · 1 center
- Seoul National University Hospital — Seoul
Identifiers
NCT: NCT07054502 · 2503-210-1630